EMR One-Pagers — Q-Site Medspa Survey
Eight EMRs ranked by user satisfaction. Each card shows who uses the platform, what users love and hate (in their own words), and the Moxie-positioning read. Based on 152 medspa respondents, Feb 24 – Mar 30, 2026.
Satisfaction = 1–7 scale (1 Extremely Dissatisfied → 7 Extremely Satisfied)
Survey average = 5.38/7
Revenue bands:
<$20k/mo
$20–100k/mo
$100k+/mo
n = 8directional
88%satisfied or better
0%dissatisfied
Revenue
Mid-market cluster — 75% at $20–100k/mo, very few at either extreme
Providers
047+
Owner-led — 75% of owners still treat patients
Locations
88% single-location
Data & Reporting
Strong
"reporting features provide insights into revenue, staff performance"
What they love
- Low price"cheap"; "upfront cost"
- Reports"insights into revenue, staff performance"
- Ease + workflow fit"integrates well with workflow"
What they hate
- Almost nothing — one isolated complaint"not very intuitive"
- Structural risk: users cluster small — may outgrow the platform
Moxie Play
Concede the segment. Vagaro owns the price-happy <$100k tier and its users aren't shopping (zero decliners in the sample). Focus poach energy upmarket on Zenoti, Nextech, and Boulevard.
n = 5directional
80%satisfied or better
0%dissatisfied
Revenue
Wide spread — two users under $20k, two at $50–100k, one at $100k+
Providers
047+
Solo practitioners — owner IS the practice; NP/PA/RN/DO skew (no MDs)
Locations
100% single-location
Data & Reporting
Blind spot
No reporting complaints — but 3 of 5 users don't track gross margins at all (early-stage blind spot)
What they love
- Completeness"by far the most complete EMR out there" — said by a respondent who had used 5 other EMRs
- Reliability + ease"it always works… very user friendly"
- Service + transparency"they do what they sold they're gonna do"
What they hate
- No mobile app"I wish it had an app on my phone"
- Price flagged once"it's great but expensive"
Moxie Position
Completeness + service is the moat, and Moxie users are the fastest growers in the survey (3 of 5 grew 21–50%). Close the mobile gap and get ahead of "expensive" with ROI framing before Prospyr or Boulevard weaponize either.
n = 13respondents
54%satisfied or better
0%dissatisfied
Revenue
Mid-to-upper — most at $20–100k; a third at $100k+
Providers
047+
All owner-operators; MD-led (38%)
Locations
85% single-location
Data & Reporting
Strong
"full relational database for reporting" — 31% run formal dashboards, the most data-driven of any EMR
What they love
- Full-featured reporting"full relational database for reporting"
- Customizable"easy to customize, offers all features we need"
- Everyday simplicity"simple to use for everyday tasks"
What they hate
- Bugs + glitches"still has a lot of bugs"; "has a few glitches"
- Slow support + weak integrations"could be better/quicker with support"
- Lead indicatorone user: "it's just OK. Will probably change."
Moxie Play
Retention champions stuck on a tolerated tool, and half are declining — they need a growth narrative, not a feature brochure. Lead with reporting depth and actual support velocity.
n = 24largest sample
50%satisfied or better
0%dissatisfied
Revenue
Widest spread of any EMR — equal quarters at both ends, half in the middle
Providers
047+
Small teams; 42% of owners generate >75% of revenue themselves
Locations
75% single-location
Data & Reporting
Weak
Flagged as the #1 improvement area — "would like more integrations and easier reporting"
What they love
- Price"the price can't be beat"; "best priced EMR"
- Ease"user-friendly"; "feature-rich and easy to use"
- Before/after photos"after photos ghost over the before so I get a perfect match"
- Responsive support"issues have gotten resolved"
What they hate
- Weak on wellness / HRT"clunky for hormone replacement"; "doesn't integrate with labs"
- Limited reporting — flagged as top improvement area
- Booking portal"managing monthly promotions and booking portal is very clunky"
Moxie Play
AR owns affordable, aesthetics-only. The wedge is anything beyond injectables: wellness, HRT, labs. Target AR users expanding service lines, not defending them.
n = 21respondents
62%satisfied or better
5%dissatisfied
Revenue
Broad mix — but lowest median profit of any EMR despite the top-tier share
Providers
047+
Split — some owners delegate, some still inject themselves
Locations
67% single, 33% multi-location
Data & Reporting
Mixed
One positive — "great reports" — but 57% of users sit at $0–10k profit (lowest tracking rigor) and charting is "not the best for documentation"
What they love
- Scheduling"easy booking"; "great scheduling platform"
- Bundled marketing"marketing and text messaging included"
- Customizable forms"forms that automatically attach to appointments"
What they hate
- Outages"system goes down often"; "system crashes" (4 mentions — most of any EMR)
- Cost"very expensive per month"
- Weak charting"not the best for charting"
- No human support"no access to talk to a person"
Moxie Play
Reliability cracks and a third of users in revenue decline — the trust is eroding. Target practices that outgrew scheduling-first needs; lead with clinical depth, uptime, and a human on the phone.
n = 14respondents
50%satisfied or better
7%dissatisfied
Revenue
Solid revenue — 43% at $100k+/mo, only 7% under $20k; MD-led (36%)
Providers
047+
Fully delegated — only 7% of owners still inject
Locations
71% single, 21% at 2–3 locations
Data & Reporting
Weak
Aging platform. 36% of users don't know or don't track their gross margins — alarming for practices this mature
What they love
- Longevity + familiarity"used for 10+ years"; "most comprehensive charting"
- E-prescribing"integrated to send electronic prescriptions"
- RX Photo integration"easy to use once set up"
What they hate
- Aging platform"older platform that has not advanced with growing needs"
- Trapped by data"out of date but our client base is too large to move"
- Slow + no weekend support"slow loading"; "no service on the weekend"
Moxie Play
Users are trapped by migration cost, not loyalty. These are high-transaction-value mature practices in revenue decline — a data-migration offer is the unlock, not feature parity.
n = 21respondents
43%satisfied or better
19%dissatisfied
Revenue
Enterprise skew by far — 62% at $100k+/mo (24% over $250k)
Providers
047+
Highest of any EMR. 52% of owners generate <25% of revenue — true delegators
Locations
Most multi-location of any EMR (38% at 2+, 10% at 4+)
Data & Reporting
Weak
"the reporting sucks"; "conflicting numbers" (4 mentions). 52% bolt on a separate CRM because the built-in tools aren't enough
What they love
- All-in-one"best all-in-one software for EMR/POS/analytics"
- AI features"they keep adding more AI features"
- Onboarding training"personalized training for every staff member"
What they hate
- Zero support"zero customer support"; "difficult to speak with someone" (5 mentions)
- Overcomplicated"stupid complicated"; "not user friendly"
- Price creep"increase price with every single addition"
- iPad lag"at least 75% of the time we have had issues with lags"
Moxie Play
Biggest prize. Enterprise-sized + losing ground (19% declining despite top revenue) + furious. "They do what they sold they're gonna do" lands hardest here — one respondent wrote a 200-word teardown, which means they're already shopping.
n = 8directional
38%satisfied or better
50%dissatisfied
Revenue
No small practices — all at $20k+; 25% over $250k; 50% "Other" license (non-clinical)
Providers
047+
Mostly delegated — non-clinical ownership common
Locations
62% single-location, 38% multi-location
Data & Reporting
Weak
"reporting is not good." 75% of users bolt on a separate CRM — highest rate in the survey
What they love
- GHL integration + go-live team (one recent switcher)
- One user reported smooth day-to-day operation — the rest are struggling
What they hate
- Ancient UI"floppy disk as the save button"; "old DOS interface"
- Slow + clunky"very slow and clunky from a charting standpoint"
- Not medspa-native"not set up for a medical spa"
- Reporting"reporting is not good"
Moxie Play
Plastic-surgery tool forced into medspa. 50% dissatisfied, highest marketing spend in the survey trying to compensate, 75% bolting on a separate CRM. Easiest acquisition targets — they know the tool is failing.